196 related articles for article (PubMed ID: 37669943)
1. Neutrophil metalloproteinase driven spleen damage hampers infection control of trypanosomiasis.
Pham HTT; Magez S; Choi B; Baatar B; Jung J; Radwanska M
Nat Commun; 2023 Sep; 14(1):5418. PubMed ID: 37669943
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma brucei brucei causes a rapid and persistent influx of neutrophils in the spleen of infected mice.
Deleeuw V; Phạm HTT; De Poorter I; Janssens I; De Trez C; Radwanska M; Magez S
Parasite Immunol; 2019 Oct; 41(10):e12664. PubMed ID: 31325372
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
[TBL] [Abstract][Full Text] [Related]
4. T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis.
Bockstal V; Guirnalda P; Caljon G; Goenka R; Telfer JC; Frenkel D; Radwanska M; Magez S; Black SJ
PLoS Pathog; 2011 Jun; 7(6):e1002089. PubMed ID: 21738467
[TBL] [Abstract][Full Text] [Related]
5. Mouse experiments demonstrate differential pathogenicity and virulence of Trypanosoma brucei rhodesiense strains.
Kipkorir LW; John TK; Owino OB; John O; Robert S; Daniel M; Owino AV
Exp Parasitol; 2021 Sep; 228():108135. PubMed ID: 34284027
[TBL] [Abstract][Full Text] [Related]
6. Single-cell transcriptome profiling and the use of AID deficient mice reveal that B cell activation combined with antibody class switch recombination and somatic hypermutation do not benefit the control of experimental trypanosomosis.
Nguyen HTT; Guevarra RB; Magez S; Radwanska M
PLoS Pathog; 2021 Nov; 17(11):e1010026. PubMed ID: 34762705
[TBL] [Abstract][Full Text] [Related]
7. Murine trypanosomiasis: cellular proliferation and functional depletion in the blood, peritoneum, and spleen related to changes in bone marrow stem cells.
Clayton CE; Selkirk ME; Corsini CA; Ogilvie BM; Askonas BA
Infect Immun; 1980 Jun; 28(3):824-31. PubMed ID: 7399696
[TBL] [Abstract][Full Text] [Related]
8. Plasma cytokines quantification among
Kamoto K; Chiwaya A; Nambala P; Chammudzi P; Senga E; Chisi J; Matovu E; Musaya J
Malawi Med J; 2021 Dec; 33(4):230-235. PubMed ID: 35291381
[TBL] [Abstract][Full Text] [Related]
9. Blood signatures for second stage human African trypanosomiasis: a transcriptomic approach.
Mulindwa J; Matovu E; Enyaru J; Clayton C
BMC Med Genomics; 2020 Jan; 13(1):14. PubMed ID: 32000760
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of peripheral blood immunoinflammatory landscapes in patients with acute cholangitis and its secondary septic shock using single-cell RNA sequencing.
Zhang H; Wang N; Xu Y; Pei M; Zheng Y
Biochem Biophys Res Commun; 2023 Nov; 683():149121. PubMed ID: 37864923
[TBL] [Abstract][Full Text] [Related]
11. Vitamin B12 blocked Trypanosoma brucei rhodesiense-driven disruption of the blood brain barrier, and normalized nitric oxide and malondialdehyde levels in a mouse model.
Oula JO; Mose JM; Waiganjo NN; Chepukosi KW; Mitalo NS; Isaac AO; Nyariki JN
Parasitol Int; 2023 Oct; 96():102775. PubMed ID: 37390918
[TBL] [Abstract][Full Text] [Related]
12.
Cooper A; Ilboudo H; Alibu VP; Ravel S; Enyaru J; Weir W; Noyes H; Capewell P; Camara M; Milet J; Jamonneau V; Camara O; Matovu E; Bucheton B; MacLeod A
Elife; 2017 May; 6():. PubMed ID: 28537557
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with acquisition of human infective and animal infective trypanosome infections in domestic livestock in Western Kenya.
von Wissmann B; Machila N; Picozzi K; Fèvre EM; deC Bronsvoort BM; Handel IG; Welburn SC
PLoS Negl Trop Dis; 2011 Jan; 5(1):e941. PubMed ID: 21311575
[TBL] [Abstract][Full Text] [Related]
14. Quantifying the association between bovine and human trypanosomiasis in newly affected sleeping sickness areas of Uganda.
von Wissmann B; Fyfe J; Picozzi K; Hamill L; Waiswa C; Welburn SC
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2931. PubMed ID: 24901845
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.
Rodgers J; Stone TW; Barrett MP; Bradley B; Kennedy PG
Brain; 2009 May; 132(Pt 5):1259-67. PubMed ID: 19339256
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness).
Kennedy PG
Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189
[TBL] [Abstract][Full Text] [Related]
17. Application of the enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of human African trypanosomiasis (sleeping sickness).
Ruitenberg EJ; Buys J
Am J Trop Med Hyg; 1977 Jan; 26(1):31-6. PubMed ID: 320895
[TBL] [Abstract][Full Text] [Related]
18. The serum-formalin reaction in Trypanosoma rhodesiense sleeping sickness.
COOKSON LO
J Trop Med Hyg; 1947 Jul; 50(7):134-40. PubMed ID: 20256846
[No Abstract] [Full Text] [Related]
19. Chemotherapy of African sleeping sickness. III. Chemotherapy of experimental Trypanosoma gambiense and Trypanosoma rhodesiense infections in mice with captostibone.
PACKCHANIAN A
Trans R Soc Trop Med Hyg; 1957 May; 51(3):257-64. PubMed ID: 13443017
[No Abstract] [Full Text] [Related]
20. Human African trypanosomiasis.
Lejon V; Bentivoglio M; Franco JR
Handb Clin Neurol; 2013; 114():169-81. PubMed ID: 23829907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
